BMI-2002 Study: Evaluation of Functionality and Evolution of Body Weight of Psychotic Patients With a High Body Mass Index.

Trial Profile

BMI-2002 Study: Evaluation of Functionality and Evolution of Body Weight of Psychotic Patients With a High Body Mass Index.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 18 May 2011

At a glance

  • Drugs Risperidone (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 19 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top